This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Abacus Life, Inc. (ABL) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Abacus Life, Inc. (ABL) delivered earnings and revenue surprises of 42.86% and 7.93%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
F&G Annuities & Life, Inc. (FG) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
F&G Annuities & Life, Inc. (FG) delivered earnings and revenue surprises of 2.52% and 22.79%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in Abacus Life (ABL) Stock?
by Zacks Equity Research
Investors need to pay close attention to Abacus Life (ABL) stock based on the movements in the options market lately.
Sun Life (SLF) Q3 Earnings Top Estimates
by Zacks Equity Research
Sun Life (SLF) delivered earnings and revenue surprises of 3.20% and 5.19%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Abacus Life, Inc. (ABL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Abacus Life, Inc. (ABL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Do Options Traders Know Something About Abacus Life (ABL) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Abacus Life (ABL) stock based on the movements in the options market lately.
Nasdaq Expands Presence in Latin America With New Agreement
by Zacks Equity Research
Nasdaq extends agreement with Nubank to provide AxiomSL regulatory reporting solution to the later and expands presence in Latin America.
What Makes Abacus Life, Inc. (ABL) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Abacus Life, Inc. (ABL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Buy 4 Low-Beta Stocks & Forget About Volatility: ERIE, SFM, AVO, ABL
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. ERIE, SFM, AVO & ABL are well-poised to gain.
Strength Seen in Abacus Life, Inc. (ABL): Can Its 5.4% Jump Turn into More Strength?
by Zacks Equity Research
Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Does Abacus Life, Inc. (ABL) Have the Potential to Rally 34.62% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Abacus Life, Inc. (ABL) points to a 34.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Do Options Traders Know Something About Abacus Life (ABL) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Abacus Life (ABL) stock based on the movements in the options market lately.
Cboe Global Rallies 17% YTD: Can the Stock Retain the Bull Run?
by Zacks Equity Research
CBOE's strong market position, global reach, proprietary products strength and solid capital position poise it well for growth.
Can Abacus Life, Inc. (ABL) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Abacus Life, Inc. (ABL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Predict a 32.72% Upside in Abacus Life, Inc. (ABL): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 32.7% upside potential for Abacus Life, Inc. (ABL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
GoHealth (GOCO) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
GoHealth (GOCO) delivered earnings and revenue surprises of 69.64% and 23.83%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
FinWise Bancorp (FINW) Tops Q2 Earnings Estimates
by Zacks Equity Research
FinWise Bancorp (FINW) delivered earnings and revenue surprises of 41.18% and 0.19%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Abacus Life, Inc. (ABL) Stock Jumps 20.3%: Will It Continue to Soar?
by Zacks Equity Research
Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.